Development of an oral rutin nanocrystal formulation

被引:201
作者
Mauludin, Rachmat [1 ]
Mueller, Rainer H. [1 ]
Keck, Cornelia M. [1 ]
机构
[1] Free Univ Berlin, Dept Pharmaceut Biopharmaceut & NutriCosmet, D-12169 Berlin, Germany
关键词
Nanocrystals; Rutin; Lyophilization; Re-dispersion; Rutin nanocrystal-loaded tablet; Dissolution behavior; PARTICLE-SIZE REDUCTION; POORLY SOLUBLE DRUGS; DISSOLUTION RATE; BIOAVAILABILITY; NANOSUSPENSIONS; FLAVONOIDS; IMPROVEMENT; SOLUBILITY; ABSORPTION; QUERCETIN;
D O I
10.1016/j.ijpharm.2008.11.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dried rutin nanocrystals have been prepared by lyophilization and investigated regarding their physicochemical properties with respect to re-dispersability, particle size, morphology and dissolution behavior. Photon correlation spectroscopy (PCS) and laser diffractometry (LD) were employed to determine the particle size. Morphology of the particles was analyzed by light microscopy. Lyophilized rutin nanocrystals were incorporated into tablets and the dissolution behavior of the tablets was evaluated. Very fine particles of lyophilized rutin could be completely re-dispersed in the water. The PCS size average and polydispersity index (PI) of lyophilized rutin were of 721 nm and of 0.288 after re-dispersion. The rutin nanocrystal-loaded tablets were produced using direct compression. The dissolution velocity of the rutin nanocrystal-loaded tablet was superior compared to rutin microcrystal-loaded and a marketed tablet. After 30 min rutin was released and dissolved completely from the nanocrystal tablets in water. In contrast, only 71% and 55% of the total amount of rutin were dissolved from the microcrystal tablets and the marketed tablet, respectively. The improving dissolution behavior of the rutin nanocrystal-loaded tablet should lead to a better bioavailability of the poorly soluble rutin in the body. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 58 条
[1]  
Auweter H, 2002, US Patent, Patent No. 6494924
[2]   THE RELATIONSHIP BETWEEN PARTICLE-SIZE AND SOLUBILITY [J].
BUCKTON, G ;
BEEZER, AE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 82 (03) :R7-R10
[3]   Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients [J].
Busignies, V. ;
Leclerc, B. ;
Porion, P. ;
Evesque, P. ;
Couarraze, G. ;
Tchoreloff, P. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (01) :66-74
[4]   The rutin/β-cyclodextrin interactions in fully aqueous solution:: spectroscopic studies and biological assays [J].
Calabrò, ML ;
Tommasini, S ;
Donato, P ;
Stancanelli, R ;
Raneri, D ;
Catania, S ;
Costa, C ;
Villari, V ;
Ficarra, P ;
Ficarra, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 36 (05) :1019-1027
[5]   Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation [J].
Chen, SS ;
Gong, J ;
Liu, FT ;
Mohammed, U .
IMMUNOLOGY, 2000, 100 (04) :471-480
[6]  
DAY AJ, 2001, BR J NUTR, pS105
[7]   QUERCETIN AND RUTIN AS INHIBITORS OF AZOXYMETHANOL-INDUCED COLONIC NEOPLASIA [J].
DESCHNER, EE ;
RUPERTO, J ;
WONG, G ;
NEWMARK, HL .
CARCINOGENESIS, 1991, 12 (07) :1193-1196
[8]  
FICHTINGER A, 2004, THESIS FREIE U BERLI
[9]   Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine [J].
Hecq, J ;
Deleers, M ;
Fanara, D ;
Vranckx, H ;
Amighi, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 299 (1-2) :167-177
[10]   THE EFFECT OF PARTICLE-SIZE DISTRIBUTION ON DISSOLUTION RATE AND ORAL ABSORPTION [J].
HINTZ, RJ ;
JOHNSON, KC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :9-17